McLellan L I, Judah D J, Neal G E, Hayes J D
Department of Clinical Biochemistry, University of Edinburgh, Royal Infirmary, U.K.
Biochem J. 1994 May 15;300 ( Pt 1)(Pt 1):117-24. doi: 10.1042/bj3000117.
Ingestion of aflatoxin B1 (AFB1) represents a major risk factor in the aetiology of human hepatocellular carcinoma. In the rat, the harmful effects of AFB1 can be prevented by the administration of certain drugs which induce hepatic detoxification enzymes. We have previously shown that treatment of rats with the chemoprotector ethoxyquin (EQ) results in a marked increase in expression of the Alpha-class glutathione S-transferase (GST) Yc2 subunit which has high activity towards AFB1-8,9-epoxide [Hayes, Judah, McLellan, Kerr, Peacock and Neal (1991) Biochem. J. 279, 385-398]. To allow an assessment of whether the increased expression of GST Yc2 represents a general adaptive resistance mechanism to chemical stress, that is invoked by both chemoprotectors and carcinogens, we have examined the effects of EQ, butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), phenobarbital (PB), AFB1, 3-methylcholanthrene (3-MC) and clofibrate on the AFB1-glutathione-conjugating activity and the GST subunit levels in rat liver. In addition, the effect of these drugs on the hepatic levels of an aldehyde reductase (AFB1-AR) that metabolizes the cytotoxic dialdehydic form of AFB1 has been studied as this enzyme also appears to be important in chemoprotection. Administration of the antioxidants EQ, BHA or BHT, as well as PB, led to a marked increase in levels of the GST Yc2 subunit in rat liver, and this increase coincided with a substantial rise in the GST activity towards AFB1-8,9-epoxide; neither AFB1, 3-MC nor clofibrate caused induction of Yc2 or any of the GST subunits examined. Among the xenobiotics studied, EQ was found to be the most effective inducing agent for the Yc2 subunit as well as Yc1, Yb1 and Yf. However, PB was equally as effective as EQ in increasing levels of the Ya-type subunits, although it was not found to be as potent an inducer of the other GST subunits, including Yc2. In addition to induction of GST, EQ caused a substantial increase in the hepatic content of AFB1-AR. Both BHA and BHT were also able to induce this enzyme but, by contrast, PB was found to be a poor inducer of AFB1-AR. AFB1, 3-MC and clofibrate were unable to serve as inducers of this reductase. The presence of Alpha-class GST, including the Yc2 subunit, was examined in various rat tissues. Constitutive expression of Yc2 was found in the epididymis at levels comparable with that observed in the liver from EQ-treated rats.(ABSTRACT TRUNCATED AT 400 WORDS)
摄入黄曲霉毒素B1(AFB1)是人类肝细胞癌病因中的一个主要风险因素。在大鼠中,某些诱导肝脏解毒酶的药物可以预防AFB1的有害影响。我们之前已经表明,用化学保护剂乙氧喹(EQ)处理大鼠会导致α类谷胱甘肽S-转移酶(GST)Yc2亚基的表达显著增加,该亚基对AFB1-8,9-环氧化物具有高活性[海斯、朱达、麦克莱伦、克尔、皮科克和尼尔(1991年)《生物化学杂志》279卷,385 - 398页]。为了评估GST Yc2表达的增加是否代表对化学应激的一种普遍适应性抗性机制,即由化学保护剂和致癌物共同引发的机制,我们研究了EQ、丁基羟基茴香醚(BHA)、丁基羟基甲苯(BHT)、苯巴比妥(PB)、AFB1、3-甲基胆蒽(3-MC)和氯贝丁酯对大鼠肝脏中AFB1-谷胱甘肽结合活性和GST亚基水平的影响。此外,还研究了这些药物对一种醛还原酶(AFB1-AR)肝脏水平的影响,该酶代谢AFB1的细胞毒性二醛形式,因为这种酶在化学保护中似乎也很重要。给予抗氧化剂EQ、BHA或BHT以及PB会导致大鼠肝脏中GST Yc2亚基水平显著增加,并且这种增加与对AFB1-8,9-环氧化物的GST活性大幅上升同时出现;AFB1、3-MC和氯贝丁酯均未引起Yc2或所检测的任何GST亚基的诱导。在所研究的外源性物质中,发现EQ是Yc2亚基以及Yc1、Yb1和Yf最有效的诱导剂。然而,PB在增加Ya型亚基水平方面与EQ同样有效,尽管它不是其他GST亚基(包括Yc2)的强效诱导剂。除了诱导GST外,EQ还导致AFB1-AR的肝脏含量大幅增加。BHA和BHT也能够诱导这种酶,但相比之下,发现PB是AFB1-AR的弱诱导剂。AFB1、3-MC和氯贝丁酯不能作为这种还原酶的诱导剂。在大鼠的各种组织中检测了包括Yc2亚基在内的α类GST的存在情况。发现附睾中Yc2的组成型表达水平与用EQ处理的大鼠肝脏中观察到的水平相当。(摘要截取自400字)